| DC Field | Value | Language |
|---|
| dc.contributor.author | Peresypkina, A. A. | - |
| dc.contributor.author | Levkova, E. A. | - |
| dc.contributor.author | Yakushev, V. I. | - |
| dc.contributor.author | Bunyatyan, N. D. | - |
| dc.contributor.author | Churnosov, M. I. | - |
| dc.date.accessioned | 2018-04-24T07:19:59Z | - |
| dc.date.available | 2018-04-24T07:19:59Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Correction of retinal ischemia/reperfusion by 3-(1H-benzimidazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid in experiment / A.A. Peresypkina [et al.] // International Journal of Advanced Biotechnology and Research. - 2018. - Vol.9, N1.-P. 997-1001. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/21795 | - |
| dc.description.abstract | Results of ocular fundus studies revealed the most pronounced protective effects of 3-(1Hbenzimidazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid in a dose 50 mg/kg on the model of retinal ischemiareperfusion in Wistar rats, which is reflected in the restoration of the optic disc. Correction of retinal ischemiareperfusion by 3-(1H-benzimidazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid in a dose 50 mg/kg leads to higher values of the coefficient b/a of electroretinography after 72 hours of reperfusion compared to the group with pathology correction by the same drug in a dose 10 mg/kg, which indicates the restoration of the electrophysiological state of the retina | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | ophthalmology | ru |
| dc.subject | retinal ischemia | ru |
| dc.subject | experiment | ru |
| dc.title | Correction of retinal ischemia/reperfusion by 3-(1H-benzimidazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid in experiment | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
